Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial

OBJECTIVE: To compare the Ki-67 index of endometrial cancer cells before and after treatment between the metformin and placebo group in women with endometrial cancer (EC). METHODS: This study was a randomized, double-blind, placebo-controlled trial conducting in non-diabetic women who diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Petchsila, Kittisak, Prueksaritanond, Nisa, Insin, Putsarat, Yanaranop, Marut, Chotikawichean, Nutpacha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437343/
https://www.ncbi.nlm.nih.gov/pubmed/32212801
http://dx.doi.org/10.31557/APJCP.2020.21.3.733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437343/
https://www.ncbi.nlm.nih.gov/pubmed/32212801
http://dx.doi.org/10.31557/APJCP.2020.21.3.733

Ejemplares similares